Immunic (IMUX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

IMUX Immunic

Watchlist

1.450
+0.060+4.32%

Close Jul 26 16:00 ET

1.410
-0.040-2.76%

Post 20:02 ET

130.61MMarket Cap-792P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Immunic, Inc. Strengthens Its Board of Directors With the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec
ReutersJul 24 06:30 ET
Immunic Appoints Simona Skerjanec to Board of Directors | NASDAQ:IMUX
Proactive InvestorsJul 24 05:19 ET
Immunic Stock (NASDAQ:IMUX): Exploring the Promising Phase 2 CALLIPER Trial
TipRanksJul 22 05:27 ET
Express News | Piper Sandler Reiterates Overweight on Immunic, Maintains $28 Price Target
BenzingaJul 16 11:44 ET
Immunic Analyst Ratings
BenzingaJul 16 11:42 ET
Immunic Names Jason Tardio as COO, Werner Gladdines as Chief Development Officer
MT NewswiresJul 9 08:36 ET

Comments

Trytosaveabit

Apr 30 05:32

Update!

$Immunic(IMUX.US)$ Immunic Announces Publication of Extended Data From Phase 2 Emphasis Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation

Meltyy

Mar 20 10:18

Biotech Stock News 3/20

$Annovis Bio(ANVS.US)$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...

Trytosaveabit

Mar 20 05:31

News

$Immunic(IMUX.US)$ Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States
PR Newswire· 1 min ago